Top

Published in:

01-09-2002 | Article

Expression of CD44s in human colorectal cancer

Authors: Mousa Khoursheed, T. C. Mathew, R. R. Makar, L. Sonia, H. Abul, S. Asfar, H. Al-Sayer, H. M. Dashti, A. Al-Bader

Published in: Pathology & Oncology Research | Issue 3/2002

Title: Expression of CD44s in human colorectal cancer
Authors: Mousa Khoursheed
T. C. Mathew
R. R. Makar
L. Sonia
H. Abul
S. Asfar
H. Al-Sayer
H. M. Dashti
A. Al-Bader
Publication date: 01-09-2002
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 3/2002
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF03032390

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2002

Primary neuroendocrine carcinoma of the mediastinum

Concurrent paclitaxel-cisplatin and twice-a-day irradiation in stage IIIA and IIIB NSCLC shows improvement in local control and survival with acceptable hematologic toxicity

Combined occurrence of prostate carcinoma and malacoplakia

Molecular pathology of tumor metastasis

Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer